Pfizer Inc. (PFE) Announces Successful Completion of Initial Cash Tender Offer for Outstanding Shares of Icagen, Inc. (ICGN) and Commencement of Subsequent Offering Period  
9/6/2011 11:04:47 AM

NEW YORK & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) (“Pfizer”) and Icagen, Inc. (NASDAQ: ICGN) (“Icagen”) announced today the successful completion of the initial cash tender offer by Pfizer’s wholly-owned subsidiary, Eclipse Acquisition Corp. (“Eclipse”), for all of the outstanding shares of common stock of Icagen for $6.00 per share, paid to the seller in cash, without interest thereon, less any applicable withholding and transfer taxes.